A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Condition:   Heart Failure Interventions:   Drug: Finerenone;   Drug: Empagliflozin Sponsors:   Colorado Prevention Center;   Saint Luke's Hospital of Kansas City;   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials